Reply
- PMID: 38488278
- DOI: 10.1111/trf.17736
Reply
Comment on
-
In response: Caution in extrapolating hypercoagulable viscoelastic coagulation test results to in vivo hemostasis.Transfusion. 2024 Mar;64(3):563-564. doi: 10.1111/trf.17734. Transfusion. 2024. PMID: 38488286 No abstract available.
References
REFERENCES
-
- Butt AL, Ramarapu S, Kyo H, Tanaka KA. Caution in extrapolating hypercoagulable viscoelastic coagulation test results to in vivo hemostasis. Transfusion. (in press).
-
- Swift MM, Fair JH, Pivalizza EG. Inversed, disproportionate contribution of fibrinogen to clot strength. Transfusion. 2023;63:2021-2022. https://doi.org/10.1111/trf.17560
-
- Chapman MP, Moore EE, Burneikis D, Moore HB, Gonzalez E, Anderson KC, et al. Thrombelastographic pattern recognition in renal disease and trauma. J Surg Res. 2015;194:1-7. https://doi.org/10.1016/j.jss.2014.12.012
-
- Abdelmaguid A, Roberts LN, Tugores L, Joslin JR, Hunt BJ, Parmar K, et al. Evaluation of novel coagulation and platelet function assays in patients with chronic kidney disease. J Thromb Haemost. 2022;20:845-856. https://doi.org/10.1111/jth.15653
-
- Nunns GR, Moore EE, Chapman MP, Moore HB, Stettler GR, Peltz E, et al. The hypercoagulability paradox of chronic kidney disease: the role of fibrinogen. Am J Surg. 2017;214:1215-1218. https://doi.org/10.1016/j.amjsurg.2017.08.039
Publication types
LinkOut - more resources
Full Text Sources
